11 employees
Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.
2017
$3.4M
from 1 investors over 1 rounds
Alume Biosciences raised $3.4M on September 9, 2022
Investors: National Institute of Neurological Disorders and Stroke (NINDS)